267 related articles for article (PubMed ID: 33414372)
1. Molecular characteristics of primary pulmonary lymphoepithelioma-like carcinoma based on integrated genomic analyses.
Chen B; Zhang Y; Dai S; Zhou P; Luo W; Wang Z; Chen X; Cheng P; Zheng G; Ren J; Yang X; Li W
Signal Transduct Target Ther; 2021 Jan; 6(1):6. PubMed ID: 33414372
[TBL] [Abstract][Full Text] [Related]
2. Genomic Landscapes of Epstein-Barr Virus in Pulmonary Lymphoepithelioma-Like Carcinoma.
Wu YX; Zhang WL; Wang TM; Liao Y; Zhang YJ; Xiao RW; Jia YJ; Wu ZY; Deng CM; Yang DW; Xue WQ; He YQ; Zheng XH; Li XZ; Zhou T; Zhang PF; Zhang SD; Hu YZ; Zhang JB; Jia WH
J Virol; 2022 Feb; 96(4):e0169321. PubMed ID: 34908446
[TBL] [Abstract][Full Text] [Related]
3. Primary pulmonary lymphoepithelioma-like carcinoma is characterized by high PD-L1 expression, but low tumor mutation burden.
Wu Q; Wang W; Zhou P; Fu Y; Zhang Y; Shao YW; Jiang L
Pathol Res Pract; 2020 Aug; 216(8):153043. PubMed ID: 32703503
[TBL] [Abstract][Full Text] [Related]
4. PD-1/PD-L1 combined with LAG3 is associated with clinical activity of immune checkpoint inhibitors in metastatic primary pulmonary lymphoepithelioma-like carcinoma.
Zhong YM; Yin K; Chen Y; Xie Z; Lv ZY; Yang JJ; Yang XN; Zhou Q; Wang BC; Zhong WZ; Gao LL; Zhou WB; Chen J; Tu HY; Liao RQ; Zhang DK; Zhang SL; Lu DX; Zheng HB; Zhang HH; Wu YL; Zhang XC
Front Immunol; 2022; 13():951817. PubMed ID: 36263036
[TBL] [Abstract][Full Text] [Related]
5. Comparison of first-line immunotherapy efficacy between advanced lung squamous cell carcinoma and pulmonary lymphoepithelioma-like carcinoma: A propensity score matching multicenter study.
Zhou Y; Huang J; Lan J; Hu H; Yuan Z; Dong L; Deng H; Yue LA; Xiao Y; Yang X
J Cancer Res Ther; 2023 Aug; 19(4):1011-1018. PubMed ID: 37675730
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome Sequencing of Epstein-Barr Virus-associated Pulmonary Carcinoma With Low Lymphocytic Infiltration Shows Molecular Features Similar to Those of Classic Pulmonary Lymphoepithelioma-like Carcinoma: Evidence to Support Grouping Together as One Disease Entity.
Yeh YC; Ho HL; Lin CI; Chou TY; Wang YC
Am J Surg Pathol; 2021 Nov; 45(11):1476-1486. PubMed ID: 33927156
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of mutation of epidermal growth factor receptor (EGFR) and arrangement of anaplastic lymphoma kinase (ALK) in primary pulmonary lymphoepithelioma-like carcinoma.
Yin K; Feng HB; Li LL; Chen Y; Xie Z; Lv ZY; Guo WB; Lu DX; Yang XN; Yan WQ; Wu YL; Zhang XC
Thorac Cancer; 2020 Feb; 11(2):346-352. PubMed ID: 31794146
[TBL] [Abstract][Full Text] [Related]
9. The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma.
Hong S; Liu D; Luo S; Fang W; Zhan J; Fu S; Zhang Y; Wu X; Zhou H; Chen X; Chen G; Zhang Z; Zheng Q; Li X; Chen J; Liu X; Lei M; Ye C; Wang J; Yang H; Xu X; Zhu S; Yang Y; Zhao Y; Zhou N; Zhao H; Huang Y; Zhang L; Wu K; Zhang L
Nat Commun; 2019 Jul; 10(1):3108. PubMed ID: 31311932
[TBL] [Abstract][Full Text] [Related]
10. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ
Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of baseline Epstein-Barr virus DNA for recurrent or metastatic primary pulmonary lymphoepithelioma-like carcinoma.
Zou Q; Luo K; Kang L; Huang C; Mai J; Lin Y; Liang Y
Future Oncol; 2023 Dec; 19(37):2481-2492. PubMed ID: 38054449
[No Abstract] [Full Text] [Related]
14. Pulmonary Lymphoepithelioma-Like Carcinoma: A Mini-Review.
Hu Y; Ren S; Liu Y; Han W; Liu W
Onco Targets Ther; 2020; 13():3921-3929. PubMed ID: 32494151
[TBL] [Abstract][Full Text] [Related]
15. [Clinical Analysis of Primary Pulmonary Lymphoepithelioma-like Carcinoma in 8 Patients].
Zhao H; Chen J
Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):168-175. PubMed ID: 32209185
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes-based subtypes and genomic characteristics of EBV-associated lymphoepithelioma-like carcinoma.
Yin W; Jin J; Bao H; Chen H; Wang C; Cheng G; Wu C; Wu M; Yan J; Wu X; Shao Y; Ni X; Su D
J Pathol; 2022 Aug; 257(5):650-662. PubMed ID: 35451500
[TBL] [Abstract][Full Text] [Related]
17. Plasma EBV quantification is associated with the efficacy of immune checkpoint blockade and disease monitoring in patients with primary pulmonary lymphoepithelioma-like carcinoma.
Zhong YM; Chen J; Jiang J; Zhou WB; Gao LL; Zhang SL; Yan WQ; Chen Y; Zhang DK; Lu DX; Lv ZY; Xie Z; Huang Y; Guo WB; Wang BC; Yang JJ; Yang XN; Wu YL; Zhang XC
Clin Transl Immunology; 2024; 13(6):e1515. PubMed ID: 38835955
[TBL] [Abstract][Full Text] [Related]
18. The CT and PET/CT findings in primary pulmonary lymphoepithelioma-like carcinoma with pathological correlation: a study of 215 cases.
Lei Y; Zhou J; Liu J; Xia X; Wang P; Peng Y; Xie X; Liao Y; Wan Q; Li X
Clin Radiol; 2022 Mar; 77(3):e201-e207. PubMed ID: 35012737
[TBL] [Abstract][Full Text] [Related]
19. Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases.
Qin Y; Gao G; Xie X; Zhu Z; Guan W; Lin X; Xie Z; Ming O; Chen R; Zhong N; Li S; Zhou C
Clin Lung Cancer; 2019 May; 20(3):e329-e337. PubMed ID: 30683631
[TBL] [Abstract][Full Text] [Related]
20. Vesicle-bound EBV-BART13-3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV-infections.
Ramayanti O; Verkuijlen SAWM; Novianti P; Scheepbouwer C; Misovic B; Koppers-Lalic D; van Weering J; Beckers L; Adham M; Martorelli D; Middeldorp JM; Pegtel DM
Int J Cancer; 2019 May; 144(10):2555-2566. PubMed ID: 30411781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
